Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies

• Pubblicazione: Washington, D.C., : National Academies Press, 2009
• Edizione: 1st ed.
• Descrizione fisica: 1 online resource (149 p.)
• Disciplina: 615/.19
• Soggetto topico: Orphan drugs - Government policy - United States; Pharmaceutical policy - United States; Drugs - Design - United States
• Altri autori: WizemannTheresa M RobinsonSally GiffinRobert B
• Note generali: Bibliographic Level Mode of Issuance: Monograph
• Nota di bibliografia: Includes bibliographical references (p. 104-105).
• Nota di contenuto: Introduction and overview -- Current model for financing drug development : from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary.
• Sommario/riassunto: "The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."--P. 3.
• Titolo autorizzato: Breakthrough business models
• ISBN: 0-309-17816-9; 1-282-08355-4; 9786612083556; 0-309-12089-6
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910812068203321
• Lo trovi qui: Univ. Federico II